Su Haizhen, Zhu QianYing, Zhang Yi, Xia Fei, Zhu Mengchu, Jiang Lei, Zhang Qing
Department of Clinical Laboratory, Ruian People's Hospital, WenZhou, Zhejiang, China.
Department of Respiratory Medicine, Ruian People's Hospital, WenZhou, Zhejiang, China.
BMC Infect Dis. 2025 Jun 4;25(1):792. doi: 10.1186/s12879-025-11167-z.
Nocardia farcinica, a gram-positive filamentous bacterium, is predominantly found in individuals with compromised immune systems. Bacteremia caused by Nocardia farcinica is relatively rare.
A 58-year-old woman who was diagnosed with systemic lupus erythematosus (SLE) for more than three months presented with a fever that persisted for three days. Following comprehensive diagnostic evaluations, including antinuclear and anti-dsDNA antibody tests, electrocardiogram, lung CT, MRI, and cultures of blood and sputum, the patient was diagnosed with Nocardia farcinica bloodstream infection and disseminated Nocardia disease affecting the intracranial, endocardial, and pulmonary regions. The patient was administered a combination ofsulfamethoxazole‒trimethoprim tablets and linezolid, for anti-infective therapy. Throughout the treatment course, the patient developed symptoms, including headache, chest pain, and back pain, which escalated to sudden confusion, pupil dilation, and ultimately cardiac arrest. Despite resuscitation efforts, the patient died.
The clinical manifestations and imaging findings of nocardiosis are nonspecific, and diagnosis largely depends on pathogen identification. Clinicians should maintain a high level of suspicion for nocardiosis in immunocompromised patients, particularly those with long-term use of corticosteroids or immunosuppressive agents, and closely monitor the risk of disseminated infection secondary to Nocardia bloodstream infection. Early diagnosis and appropriate use of multiple antibiotics are crucial. In cases of disseminated nocardiosis, especially when critical sites such as the central nervous system or endocardium are involved, a three-drug regimen is recommended to control the infection more effectively and improve patient survival outcomes.
The manuscript is a case report; therefore, I declare that a Clinical Trial number is not applicable.
豚鼠耳炎诺卡菌是一种革兰氏阳性丝状细菌,主要见于免疫系统受损的个体。豚鼠耳炎诺卡菌引起的菌血症相对罕见。
一名58岁女性,诊断为系统性红斑狼疮(SLE)三个多月,出现持续三天的发热。经过全面的诊断评估,包括抗核抗体和抗双链DNA抗体检测、心电图、肺部CT、MRI以及血液和痰液培养,患者被诊断为豚鼠耳炎诺卡菌血流感染及播散性诺卡菌病,累及颅内、心内膜和肺部区域。给予患者磺胺甲恶唑-甲氧苄啶片和利奈唑胺联合抗感染治疗。在整个治疗过程中,患者出现头痛、胸痛和背痛等症状,随后发展为突然意识模糊、瞳孔散大,最终心脏骤停。尽管进行了复苏努力,患者仍死亡。
诺卡菌病的临床表现和影像学表现不具有特异性,诊断很大程度上依赖于病原体鉴定。临床医生应高度怀疑免疫功能低下患者,尤其是长期使用糖皮质激素或免疫抑制剂的患者发生诺卡菌病,并密切监测豚鼠耳炎诺卡菌血流感染继发播散性感染的风险。早期诊断和合理使用多种抗生素至关重要。在播散性诺卡菌病的病例中,特别是当累及中枢神经系统或心内膜等关键部位时,建议采用三联药物治疗方案,以更有效地控制感染并改善患者生存结局。
该手稿为病例报告;因此,我声明不适用临床试验编号。